Concepedia

Peter M. De Porre

PM

Statistics

Publications

2

Citations

151

H-Index

2

Active since

2004

Affiliations

Johnson & Johnson (United States)(Current)

Peter M. De Porre is an author at Johnson & Johnson (United States) specializing in phase ii investigation, cancer pharmacology, and medicine.

Publications per year

2004–2007

2

Publications

2

Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer

John V. Heymach, David H. Johnson, Fadlo R. Khuri et al. · Annals of Oncology · 2004 · 89 citations · Full text

, , +10

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

Stephen Johnston, Semiglazov Vf, George Manikhas et al. · Breast Cancer Research and Treatment · 2007 · 62 citations

, , +14

1–2 of 2